Fibroblast growth factors are required for efficient tumor angiogenesis

Cancer Research

Volumn 60, Issue 24, 2000, Pages 7163-7169

  Compagni, Amelia ^a   Wilgenbus, Petra ^a   Impagnatiello, Maria Antonietta ^a   Cotton, Matt ^a   Christofori, Gerhard ^a  

^a RESEARCH INSTITUTE OF MOLECULAR PATHOLOGY   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENIC FACTOR; COLLAGEN GEL; FIBROBLAST GROWTH FACTOR; FIBROBLAST GROWTH FACTOR RECEPTOR; VASCULOTROPIN;

ADENOVIRUS; ALLOTRANSPLANTATION; ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOASSAY; CANCER INHIBITION; CARCINOGENESIS; CELL PROLIFERATION; CONTROLLED STUDY; INFECTION CONTROL; INSULINOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSGENIC MOUSE; TUMOR CELL; TUMOR VASCULARIZATION; VIRUS RECOMBINANT;

ADENOVIRIDAE; ANIMALS; APOPTOSIS; CELL DIVISION; CELLS, CULTURED; COCULTURE TECHNIQUES; COLLAGEN; DNA; DNA, COMPLEMENTARY; ENDOTHELIUM, VASCULAR; FIBROBLAST GROWTH FACTORS; HUMANS; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; MICE; MICE, NUDE; MICE, TRANSGENIC; MICROCIRCULATION; NEOPLASM TRANSPLANTATION; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; RECEPTORS, FIBROBLAST GROWTH FACTOR; TIME FACTORS; UMBILICAL VEINS;

EID: 0034671392     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. What is the evidence that tumors are angiogenesis dependent?
2. Tumoral vascularity as a prognostic factor in cancer
3. Mechanisms of angiogenesis
4. Molecular and biological properties of vascular endothelial growth factor
5. Molecular and cellular mechanisms of angiogenesis
6. Synergistic effects of vascular endothelial growth factor and basic fibroblast growth factor on the proliferation and cord formation of bovine capillary endothelial cells within collagen gels
7. Potent synergism between vascular endothelial growth factor and basic fibroblast growth factor in the induction of angiogenesis in vitro
8. Fibroblast growth factor-2 (FGF-2) induces vascular endothelial growth factor (VEGF) expression in the endothelial cells of forming capillaries: An autocrine mechanism contributing to angiogenesis
9. Regulation of vascular endothelial growth factor receptor-2 (Flk-1) expression in vascular endothelial cells
10. The FGF family of growth factors and oncogenes
11. Elevated levels of an angiogenic peptide, basic fibroblast growth factor, in the urine of patients with a wide spectrum of cancers
12. Antisense targeting of basic fibroblast growth factor and fibroblast growth factor receptor-1 in human melanomas blocks intratumoral angiogenesis and tumor growth
13. Suppression of solid tumor growth by immunoneutralizing monoclonal antibody against human basic fibroblast growth factor
14. Induction of angiogenesis during the transition from hyperplasia to neoplasia
15. Heritable formation of pancreatic β-cell tumours in transgenic mice expressing recombinant insulin/simian virus 40 oncogenes
16. Proliferation, senescence, and neoplastic progression of β cells in hyperplasic pancreatic islets
17. A causal role for E-cadherin in the transition from adenoma to carcinoma
18. Vascular endothelial growth factor and its receptors, flt-1 and flk-1, are expressed in normal pancreatic islets and throughout islet cell tumorigenesis
19. Novel forms of acidic fibroblast growth factor-1 are constitutively exported by β tumor cell lines independent from conventional secretion and apoptosis
20. Neovascularization is associated with a switch to the export of bFGF in the multistep development of fibrosarcoma
21. Paracrine expression of a native soluble vascular endothelial growth factor receptor inhibits tumor growth, metastasis, and mortality rate
22. Regional suppression of tumor growth by in vivo transfer of a cDNA encoding a secreted form of the extracellular domain of the flt-1 vascular endothelial growth factor receptor
23. Inhibition of tumor growth by targeting tumor endothelium using a soluble vascular endothelial growth factor receptor
24. Suppression of tumor angiogenesis and growth by gene transfer of a soluble form of vascular endothelial growth factor receptor into a remote organ
25. Antiangiogenic gene therapy targeting the endothelium-specific receptor tyrosine kinase Tie2
26. Soluble dominant-negative receptor uncovers essential roles for fibroblast growth factors in multi-organ induction and patterning
27. Efficient generation of recombinant adenovirus vectors by homologous recombination in Escherichia coli
28. Mutational analysis of the avian adenovirus CELO, which provides a basis for gene delivery vectors
29. A general strategy for isolation of endothelial cells from murine tissues. Characterization of two endothelial cell lines from the murine lung and subcutaneous sponge implants
30. Pancreatic β cells cultured from individual preneoplastic foci in a multistage tumorigenesis pathway: A potentially general technique for isolating physiologically representative cell lines
31. Betacellulin: A mitogen from pancreatic β cell tumors
32. The rise and fall of apoptosis during multistage tumorigenesis: Down-modulation contributes to tumor progression from angiogenic progenitors
33. Endothelial differentiation using Matrigel
34. Fibroblast growth factor receptor 4, implicated in progression of islet cell carcinogenesis by its expression profile, does not contribute functionally
35. Angiogenesis in cancer, vascular, rheumatoid and other disease
36. Antiangiogenic therapy of transgenic mice impairs de novo tumor growth
37. Effects of angiogenesis inhibitors on multistage carcinogenesis in mice
38. Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins
39. Vascular endothelial growth factor is essential for corpus luteum angiogenesis
40. Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis